News | News By Subject | News by Disease News By Date | Search News

Macular degeneration News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Ophthotech (OPHT) Plunges as Wet AMD Drug Combo Trials With Novartis AG (NVS) Flops in Phase III Studies     12/13/2016
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea     10/14/2016
San Diego’s Pfenex (PFNX) Regains Full Rights to PF582 and Announces Phase I/II Results     8/8/2016
Genentech (RHHBY) Partners Up with Novartis AG (NVS) on Ex-U.S. Rights to Wet AMD Candidate Fovista     11/17/2015
Avalanche Biotech (AAVL) Goes Back to Drawing Board, Performs More Preclinical Studies on Eye Drug     8/17/2015
Roche (RHHBY)'s Avastin Not Linked to Higher Risk of Blindness     8/14/2015
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial     5/21/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs     4/6/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants     12/11/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market     10/16/2014
Advanced Cell Technology Secures $30 Million Financing     7/3/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN)     6/26/2014

News from Around the Web
Implanted Telescope Helps Patients Overcome Macular Degeneration, VisionCare Reveals     8/26/2016
Broccoli May Help Treating Age-Related Vision Loss, Buck Institute for Age Research Study     7/7/2016
"Bionic Eye" Helps Man See After Decade Of Impaired Vision     7/23/2015
Smartphone Overuse May "Damage" Eyes, Say Opticians     4/1/2014
Compound Found in Rosemary Protects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/28/2012
Compound Found in Rosemary Pprotects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/27/2012
Omega-3 Fatty Acids Ward Off Macular Degeneration, Brigham and Women's Hospital Study     3/18/2011
Fish Oils May Protect Against Age-related Macular Degeneration, Harvard University Study     3/15/2011
Fish Oil May Thwart Advanced AMD, Johns Hopkins University Study     12/3/2010
American Academy of Ophthalmology: Bevacizumab Tops Anti-VEGF Choice in AMD, Duke University Study Finds     10/20/2010
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010
AMD Treatments Don't Increase Risk of Mortality, Duke University Study     10/12/2010
Roche (RHHBY)'s Cancer Drug Could Save Eyesight of Tens of Thousands, Moorfields Eye Hospital Study     6/14/2010
Additional Genes Associated With Age-Related Macular Degeneration Identified At National Eye Institute     4/19/2010
Poor Night Vision May Predict Age-Related Eye Disease, University of Pennsylvania School of Medicine Study     11/14/2008

Press Releases
BioTime (BTX) Announces New Positive Data From OpRegen Trial In Dry-AMD     5/9/2017
Opthea Receives Positive Feedback From European Regulatory Agencies For The OPT-302 Clinical Program In Wet AMD     3/20/2017
Tyrogenex Completes Patient Enrollment In Its Phase II Trial Of Orally Administered Vorolanib For Wet Age-Related Macular Degeneration     3/9/2017
BioTime (BTX) Release: Additional Data From Company’s OpRegen Clinical Trial in Dry-AMD to be Presented At ARVO 2017     1/19/2017
Lin Bioscience Licenses First-In-Class Therapeutic Program To Treat Dry Aged-Related Macular Degeneration From Columbia University In Collaboration With NIH     1/6/2017
Ophthotech (OPHT) Announces Results From Pivotal Phase 3 Trials Of Fovista In Wet Age-Related Macular Degeneration     12/12/2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment For Wet Age-related Macular Degeneration (Wet AMD)     12/1/2016
Opthea Completes Patient Enrolment In Phase 1/2A Wet AMD Clinical Trial     11/22/2016
Stealth Biotherapeutics Initiates Phase 1 Study Of Elamipretide In Dry Age-Related Macular Degeneration     11/14/2016
FDA Approves Genentech (RHHBY)'s Lucentis Pre-Filled Ranibizumab Syringe     10/17/2016
Regeneron (REGN) Faces Setback as Eylea Combo Drug Flunks Phase II Test     9/30/2016
Ophthotech Corporation (OPHT) Completes Patient Recruitment In Phase 3 Trial Of Fovista Anti-PDGF Therapy In Combination With Eylea Or Avastin In Wet Age-Related Macular Degeneration     6/20/2016
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Receives DSMB Approval To Start Second Patient Cohort In Clinical Trial For Dry-AMD     6/13/2016
BioTime (BTX) Announces $2.2 Million Grant For Further Development Of Dry-AMD Program     6/10/2016
SanBio, Inc. Granted Key Patent In Treatment For Macular Degeneration     5/16/2016